| | |




































membership | research programs | disease oriented working groups | related links


The UW Carbone Cancer Center (UWCCC) Nuclear Signaling Research Program seeks to understand molecular mechanisms underlying transcriptional, posttranscriptional and DNA damage responses in normal growth and differentiation processes and reveal how these mechanisms impact tumor formation, progression and therapy resistance.

Program Leader (pictured left)
Shigeki Miyamoto, PhD

Co-Leader
Caroline Alexander, PhD

 

 

 

Program Profile for Full Members

Full Membership:
20 members
12 departments
   2 schools

Project Funding as of 10/2009 (direct costs):


Peer-reviewed

$9.4M
47
NCI
$1.7M
11
NIH
$6.4M
24
ACS
$0.4M
4
 NSF
$0.1M
2
Other
$0.8M
6
Non peer-reviewed
$0.9M
12
Total
$10.3M
59


Publications
(Full members only)

 
2007
2008
2009
(6 mo)
Total
60
64
37
Intra-Programmatic*
2%
6%
8%
Inter-Progtrammatic*
28%
26%
11%

*Not mutually exclusive



Program Participants

Full Members
Elaine T. Alarid, PhD
Caroline Alexander, PhD
Richard A. Anderson
Mark E. Burkard, MD, PhD
Wade Bushman, Ph.D, MD
Sinisa Dovat, MD
Peiman Hematti, MD
David F. Jarrard, MD
James L. Keck, PhD
Shigeki Miyamoto, PhD
Jeff Ross, MD
Linda A. Schuler, PhD
Igor Slukvin, MD, PhD
John P. Svaren, PhD
James Thomson, VMD, PhD
Randal S. Tibbetts, PhD
David A. Wassarman, PhD
Jyoti J. Watters, PhD
David T. Yang, MD
Jing Zhang, PhD

Affiliate Members

Michael K Fritsch MD, PhD
Joan S. Jorgensen, DVM, PhD




Home | For Patients | Research | Shared Services | Funding | Education and Training | Outreach | About Us | Clinical Trials | Directions | Donations | Employment | Events | Find a Researcher | Newsroom | Site Map | Terms and Conditions
Copyright 2007 Board of Regents of the University of Wisconsin System